J.W. Cole Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
J.W. Cole Advisors's PFE Position: Q1 2026 in Review
J.W. Cole Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 231,791 shares — an estimated $5.15M sold.
J.W. Cole Advisors first reported a position in PFE in Q4 2019 and held it in 24 quarters. The position peaked at $8.28M in Q3 2020. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- J.W. Cole Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- J.W. Cole Advisors sold 231,791 Pfizer shares in Q1 2026, an estimated $5.15M.
- J.W. Cole Advisors first reported a position in Pfizer in Q4 2019 and held it in 24 quarters.
- J.W. Cole Advisors's Pfizer position peaked at $8.28M in Q3 2020.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on J.W. Cole Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.